H. Hilden

889 total citations
16 papers, 689 citations indexed

About

H. Hilden is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, H. Hilden has authored 16 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Cardiology and Cardiovascular Medicine and 5 papers in Epidemiology. Recurrent topics in H. Hilden's work include Lipid metabolism and disorders (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). H. Hilden is often cited by papers focused on Lipid metabolism and disorders (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Liver Disease Diagnosis and Treatment (5 papers). H. Hilden collaborates with scholars based in Finland, United States and Italy. H. Hilden's co-authors include Marja‐Riitta Taskinen, Mikko Syvänne, Esko A. Nikkilä, Jussi K. Huttunen, Hannele Yki‐Järvinen, H. Vuorinen-Markkola, Eeva Leinonen, Jamila Fruchart‐Najib, Anne Hiukka and Jean‐Charles Fruchart and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

H. Hilden

16 papers receiving 655 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Hilden Finland 13 362 235 231 191 126 16 689
Sven Chr. Enger Norway 13 329 0.9× 256 1.1× 230 1.0× 131 0.7× 156 1.2× 17 750
Regina Wikinski Argentina 17 208 0.6× 130 0.6× 190 0.8× 117 0.6× 64 0.5× 33 640
Valeria Zago Argentina 17 274 0.8× 118 0.5× 159 0.7× 185 1.0× 99 0.8× 38 605
Kirsti Hällsten Finland 15 310 0.9× 191 0.8× 159 0.7× 212 1.1× 373 3.0× 18 963
Anisa Jahangiri United States 14 189 0.5× 120 0.5× 260 1.1× 96 0.5× 92 0.7× 19 671
V J Heiling United States 11 290 0.8× 94 0.4× 115 0.5× 95 0.5× 375 3.0× 13 677
Ted A. Tobey United States 9 548 1.5× 126 0.5× 122 0.5× 239 1.3× 330 2.6× 9 857
Grace M.E. Uptergrove United States 4 169 0.5× 156 0.7× 42 0.2× 162 0.8× 181 1.4× 5 507
H. J. Voerman Netherlands 8 357 1.0× 128 0.5× 96 0.4× 51 0.3× 185 1.5× 9 559
Sandra Barbosa‐da‐Silva Brazil 17 247 0.7× 62 0.3× 116 0.5× 268 1.4× 327 2.6× 25 655

Countries citing papers authored by H. Hilden

Since Specialization
Citations

This map shows the geographic impact of H. Hilden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Hilden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Hilden more than expected).

Fields of papers citing papers by H. Hilden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Hilden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Hilden. The network helps show where H. Hilden may publish in the future.

Co-authorship network of co-authors of H. Hilden

This figure shows the co-authorship network connecting the top 25 collaborators of H. Hilden. A scholar is included among the top collaborators of H. Hilden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Hilden. H. Hilden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Verrijken, An, Sigri Beckers, Sven Francque, et al.. (2013). A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population. Obesity. 21(10). 2138–2145. 58 indexed citations
2.
Cefalù, Angelo B., Davide Noto, Maria Luisa Arpi, et al.. (2009). Novel LMF1 Nonsense Mutation in a Patient with Severe Hypertriglyceridemia. The Journal of Clinical Endocrinology & Metabolism. 94(11). 4584–4590. 49 indexed citations
3.
Cefalù, Angelo B., Davide Noto, Maria Luisa Arpi, et al.. (2009). [21] FUNCTIONAL ANALYSIS OF A NOVEL LMF1 NONSENSE MUTATION ASSOCIATED TO SEVERE HYPERTRIGLYCERIDEMIA. Nutrition Metabolism and Cardiovascular Diseases. 19. S6–S6. 1 indexed citations
4.
Hiukka, Anne, Jamila Fruchart‐Najib, Eeva Leinonen, et al.. (2005). Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes. Diabetologia. 48(6). 1207–1215. 75 indexed citations
5.
Tromm, A, Thomas Griga, H. Hilden, et al.. (2000). Orthograde whole gut irrigation with mannite versus paromomycine + lactulose as prophylaxis of hepatic encephalopathy in patients with cirrhosis and upper gastrointestinal bleeding: results of a controlled randomized trial.. PubMed. 47(32). 473–7. 25 indexed citations
6.
Liu, Ming‐Lin, Robert Bergholm, Sari Mäkimattila, et al.. (1999). A marathon run increases the susceptibility of LDL to oxidation in vitro and modifies plasma antioxidants. American Journal of Physiology-Endocrinology and Metabolism. 276(6). E1083–E1091. 95 indexed citations
7.
Luzi, Livio, Gianluca Perseghin, Enrico Regalia, et al.. (1997). Metabolic effects of liver transplantation in cirrhotic patients.. Journal of Clinical Investigation. 99(4). 692–700. 44 indexed citations
8.
Syvänne, Mikko, Philippa J. Talmud, Steve E. Humphries, et al.. (1997). Determinants of postprandial lipemia in men with coronary artery disease and low levels of HDL cholesterol. Journal of Lipid Research. 38(7). 1463–1472. 29 indexed citations
9.
Luzi, Livio, Leif Groop, Gianluca Perseghin, et al.. (1996). Effect of Pancreas Transplantation on Free Fatty Acid Metabolism in Uremic IDDM Patients. Diabetes. 45(3). 354–360. 12 indexed citations
10.
11.
Syvänne, Mikko, H. Hilden, & Marja‐Riitta Taskinen. (1994). Abnormal metabolism of postprandial lipoproteins in patients with non-insulin-dependent diabetes mellitus is not related to coronary artery disease.. Journal of Lipid Research. 35(1). 15–26. 81 indexed citations
12.
Syvänne, Mikko, H. Vuorinen-Markkola, H. Hilden, & Marja‐Riitta Taskinen. (1993). Gemfibrozil reduces postprandial lipemia in non-insulin-dependent diabetes mellitus.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(2). 286–295. 59 indexed citations
13.
Kolaczynski, Jerzy W., Marja‐Riitta Taskinen, H. Hilden, et al.. (1992). Effects of interferon alpha on insulin binding and glucose transport in human adipocytes. European Journal of Clinical Investigation. 22(4). 292–299. 8 indexed citations
14.
Järvinen, H, Eero Helve, Veikko A Koivisto, et al.. (1984). Insulin mediated glucose metabolism is unrelated to free insulin levels in type 1 insulin dependent diabetes evidence for biological activity of insulin antibodies. Diabetologia. 27(2). 347. 1 indexed citations
15.
Yki‐Järvinen, Hannele, et al.. (1984). Site of Insulin Resistance in Type 1 Diabetes: Insulin-Mediated Glucose Disposalin Vivoin Relation to Insulin Binding and Action in Adipocytesin Vitro*. The Journal of Clinical Endocrinology & Metabolism. 59(6). 1183–1192. 39 indexed citations
16.
Taskinen, Marja‐Riitta, Esko A. Nikkilä, Jussi K. Huttunen, & H. Hilden. (1980). A micromethod for assay of lipoprotein lipase activity in needle biopsy samples of human adipose tissue and skeletal muscle. Clinica Chimica Acta. 104(1). 107–117. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sven Chr. Enger Breakdown of academic impact, for papers by Regina Wikinski Breakdown of academic impact, for papers by Valeria Zago Breakdown of academic impact, for papers by Kirsti Hällsten Breakdown of academic impact, for papers by Anisa Jahangiri Breakdown of academic impact, for papers by V J Heiling Breakdown of academic impact, for papers by Ted A. Tobey Breakdown of academic impact, for papers by Grace M.E. Uptergrove Breakdown of academic impact, for papers by H. J. Voerman Breakdown of academic impact, for papers by Sandra Barbosa‐da‐Silva
Rankless by CCL
2026